Skip to main content
Caplight Logo









CurieDx

CurieDx

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://www.curiedx.com/

Last Round

Pre Seed

Mar 11, 2026

Total Funding Raised

$901,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

CurieDx is a healthcare technology company that provides an AI-powered mobile diagnostic platform for screening common illnesses like strep throat and urinary tract infections using smartphone imaging.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Medical AI, Computer Vision, Medical Imaging

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

medical AItelemedicinecomputer visionclinical decision supportremote diagnosticdigital healthAI diagnosticsvirtual careB2B SaaSmobile healthmHealthstrep throat screeningswab-free testingclinical workflowAI-powered diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CurieDx Comparables

Compare CurieDx with similar companies based on industry and business-model similarity.

CurieDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Light AI
79%
Autoderm
71%
Pfizer
69%

CurieDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 11, 2026
Pre SeedMay 14, 2025
Pre SeedJun 1, 2024
AcceleratorSep 15, 2023
GrantJun 1, 2023
Grant
Apr 23, 2022

Key People

Founding team and executive leadership

Therese Canares

Chief Executive Officer, Founder

Founding Team

Rashmi Sachan

Chief Technology Officer

Executive Team

CurieDx Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 6, 3x the trailing average.

  • Jul 13, 2026

    Open roles increased to 4, 4x the trailing average.

CurieDx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CurieDx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CurieDx's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range10
Year Founded2021
Last FundingMar 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?